100 related articles for article (PubMed ID: 15337331)
1. No effect of vitamin B-12 treatment on cognitive function and depression: a randomized placebo controlled study.
Hvas AM; Juul S; Lauritzen L; Nexø E; Ellegaard J
J Affect Disord; 2004 Sep; 81(3):269-73. PubMed ID: 15337331
[TBL] [Abstract][Full Text] [Related]
2. Cognitive performance in relation to vitamin status in healthy elderly German women-the effect of 6-month multivitamin supplementation.
Wolters M; Hickstein M; Flintermann A; Tewes U; Hahn A
Prev Med; 2005 Jul; 41(1):253-9. PubMed ID: 15917019
[TBL] [Abstract][Full Text] [Related]
3. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
Freund-Levi Y; Eriksdotter-Jönhagen M; Cederholm T; Basun H; Faxén-Irving G; Garlind A; Vedin I; Vessby B; Wahlund LO; Palmblad J
Arch Neurol; 2006 Oct; 63(10):1402-8. PubMed ID: 17030655
[TBL] [Abstract][Full Text] [Related]
4. Vitamin B(12) supplementation did not improve cognition but reduced delirium in demented patients with vitamin B(12) deficiency.
Kwok T; Lee J; Lam L; Woo J
Arch Gerontol Geriatr; 2008; 46(3):273-82. PubMed ID: 17561285
[TBL] [Abstract][Full Text] [Related]
5. Duloxetine in the treatment of Major Depressive Disorder: a comparison of efficacy in patients with and without melancholic features.
Mallinckrodt CH; Watkin JG; Liu C; Wohlreich MM; Raskin J
BMC Psychiatry; 2005 Jan; 5():1. PubMed ID: 15631624
[TBL] [Abstract][Full Text] [Related]
6. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
[TBL] [Abstract][Full Text] [Related]
7. Effects of dietary supplements on depressive symptoms in older patients: a randomised double-blind placebo-controlled trial.
Gariballa S; Forster S
Clin Nutr; 2007 Oct; 26(5):545-51. PubMed ID: 17662509
[TBL] [Abstract][Full Text] [Related]
8. Brief communication. Vitamin B1, B2, and B6 augmentation of tricyclic antidepressant treatment in geriatric depression with cognitive dysfunction.
Bell IR; Edman JS; Morrow FD; Marby DW; Perrone G; Kayne HL; Greenwald M; Cole JO
J Am Coll Nutr; 1992 Apr; 11(2):159-63. PubMed ID: 1578091
[TBL] [Abstract][Full Text] [Related]
9. A 20-week randomized controlled trial of estradiol replacement therapy for women aged 70 years and older: effect on mood, cognition and quality of life.
Almeida OP; Lautenschlager NT; Vasikaran S; Leedman P; Gelavis A; Flicker L
Neurobiol Aging; 2006 Jan; 27(1):141-9. PubMed ID: 16298249
[TBL] [Abstract][Full Text] [Related]
10. AMPA potentiator treatment of cognitive deficits in Alzheimer disease.
Chappell AS; Gonzales C; Williams J; Witte MM; Mohs RC; Sperling R
Neurology; 2007 Mar; 68(13):1008-12. PubMed ID: 17389305
[TBL] [Abstract][Full Text] [Related]
11. Walking or vitamin B for cognition in older adults with mild cognitive impairment? A randomised controlled trial.
van Uffelen JG; Chinapaw MJ; van Mechelen W; Hopman-Rock M
Br J Sports Med; 2008 May; 42(5):344-51. PubMed ID: 18308888
[TBL] [Abstract][Full Text] [Related]
12. 12-month cognitive outcomes of major and minor depression in older medical patients.
Han L; McCusker J; Cole M; Abrahamowicz M; Capek R
Am J Geriatr Psychiatry; 2008 Sep; 16(9):742-51. PubMed ID: 18757768
[TBL] [Abstract][Full Text] [Related]
13. Contribution of the MTHFR gene to the causal pathway for depression, anxiety and cognitive impairment in later life.
Almeida OP; Flicker L; Lautenschlager NT; Leedman P; Vasikaran S; van Bockxmeer FM
Neurobiol Aging; 2005 Feb; 26(2):251-7. PubMed ID: 15582752
[TBL] [Abstract][Full Text] [Related]
14. Donepezil preserves cognition and global function in patients with severe Alzheimer disease.
Black SE; Doody R; Li H; McRae T; Jambor KM; Xu Y; Sun Y; Perdomo CA; Richardson S
Neurology; 2007 Jul; 69(5):459-69. PubMed ID: 17664405
[TBL] [Abstract][Full Text] [Related]
15. Demonstration of cognitive decline in Parkinson's disease using the Cambridge Cognitive Assessment (Revised) (CAMCOG-R).
Athey RJ; Walker RW
Int J Geriatr Psychiatry; 2006 Oct; 21(10):977-82. PubMed ID: 16955442
[TBL] [Abstract][Full Text] [Related]
16. A population-based intervention study on elevated serum levels of methylmalonic acid and total homocysteine in elderly people: results after 36 months of follow-up.
Björkegren K; Svärdsudd K
J Intern Med; 2004 Nov; 256(5):446-52. PubMed ID: 15485481
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
19. Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial.
Doody RS; Ferris SH; Salloway S; Sun Y; Goldman R; Watkins WE; Xu Y; Murthy AK
Neurology; 2009 May; 72(18):1555-61. PubMed ID: 19176895
[TBL] [Abstract][Full Text] [Related]
20. Atomoxetine augmentation of cholinesterase inhibitor therapy in patients with Alzheimer disease: 6-month, randomized, double-blind, placebo-controlled, parallel-trial study.
Mohs RC; Shiovitz TM; Tariot PN; Porsteinsson AP; Baker KD; Feldman PD
Am J Geriatr Psychiatry; 2009 Sep; 17(9):752-9. PubMed ID: 19700948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
